The use of botulinum toxin in the treatment of refractory overactive bladder.
Mucksavage
Phillip
P
Division of Urology, University of Pennsylvania School of Medicine, Philadelphia, USA.
Smith
Ariana L
AL
Moy
M Louis
ML
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D012449:Safety; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration; D053201:Urinary Bladder, Overactive / Q000175:diagnosis / Q000188:drug therapy*; D014563:Urodynamics
D018726:Anti-Dyskinesia Agents; D001905:Botulinum Toxins